Hypertrophic Cardiomyopathy

19 Hypertrophic Cardiomyopathy



Hypertrophic cardiomyopathy (HCM) is the accepted term for a form of unexplained left ventricular (LV) hypertrophy that is attributable to mutations in genes encoding cardiac sarcomere proteins. Although the presentation of HCM within families varies in part because of the presence of known triggers such as hypertension, HCM is distinct from myocardial hypertrophy that develops solely in response to this sort of stimulus (Fig. 19-1). The cardinal histologic feature of HCM is myofibrillar disarray occupying 20% or more of at least one pathologic tissue block.



The annual mortality rates from HCM are approximately 6% in patients diagnosed while children and approximately 3% in patients diagnosed as adults. Patients who are older at diagnosis are often symptomatic but, in general, demonstrate slower disease progression and a more favorable prognosis. However, the 1-year mortality rate associated with HCM dramatically rises in older patients presenting with New York Heart Association (NYHA) Class III or IV congestive heart failure. Other adverse prognostic indicators are a history of atrial fibrillation or hypertension, use of digoxin and diuretics, and ECG evidence of myocardial infarction (MI). Syncope and a family history of sudden death are most predictive of sudden death. By contrast, the presence or absence of LV outflow tract obstruction may not be associated with prognosis.



Etiology and Pathogenesis


Various terms have been used to describe the phenotype of HCM. These include hypertrophic obstructive cardiomyopathy, idiopathic hypertrophic subaortic stenosis, asymmetric septal hypertrophy, and muscular subaortic stenosis—all based on the misconception that dynamic outflow tract obstruction was the key pathologic determinant of the hypertrophy (Fig. 19-2).



It is now accepted that despite the presence or absence of outflow tract obstruction, the principal abnormality is impaired ventricular compliance as a consequence of inappropriate myocardial hypertrophy and diastolic dysfunction. The nonobstructive form of HCM accounts for approximately 75% of cases.




Clinical Presentation


Some patients with HCM are asymptomatic, and the diagnosis is made after an episode of sudden cardiac arrest. The most common initial symptoms are dyspnea, chest pain, and syncope. Dyspnea is usually exertional and is reported in more than 90% of patients with HCM. Angina occurs in 75% of patients, and MI has been documented in 15% of cases at autopsy. Syncope occurs in approximately 50% of patients. There is no relation between the outflow tract gradient severity and syncopal symptoms except in some circumstances (atrial fibrillation in patients with a significant outflow gradient, see discussion below), suggesting that the most common etiology of syncope in HCM is arrhythmic.




Differential Diagnosis


LV hypertrophy (mimicking HCM) may also be present in patients with long-standing systemic hypertension (Fig. 19-3), outflow obstruction secondary to valvular heart disease (e.g., aortic stenosis or coarctation of the aorta), and infiltrative disorders of the myocardium. At times, distinguishing these conditions from HCM clinically, or even by echocardiography, can be very difficult. Tips for making this diagnostic distinction include the following: (1) in patients with aortic stenosis the gradient is fixed, unlike in patients with HCM in whom the gradient is dynamic and may fluctuate with each heartbeat; and (2) the pattern of hypertrophy seen in patients with hypertension is concentric as opposed to the pattern seen in patients with HCM, which is often distinctive, as described later in this chapter.




Diagnostic Approach



Physical Examination


The carotid impulse of the patient with the obstructive form of HCM is rapid in upstroke, bifid, and followed by a prominent dicrotic notch. This “spike-and-dome” pulse pattern is caused by rapid ventricular emptying secondary to increased LV contractility, followed by abrupt flow reduction secondary to systolic anterior motion of the mitral valve, causing partial occlusion of the outflow tract. The jugular venous pulse in sinus rhythm is characterized by prominent a waves. The outflow murmur characteristically is systolic and heard best along the left sternal border without radiation to the carotid arteries. Because the outflow tract gradient is dynamic, the murmur can be altered by various physical and pharmacologic maneuvers (see Chapter 1). It increases with amyl nitrate, Valsalva maneuvers, and upright posture, and decreases with administration of phenylephrine, squatting, and isometric handgrip.


Mitral regurgitation occurs in almost all patients with obstructive HCM. The systolic anterior motion of the mitral valve that is common in HCM results in incomplete coaptation of the mitral valve leaflets and resulting valvular regurgitation. There is also a direct relation between the LV outflow pressure gradient and the severity of mitral regurgitation. Mitral regurgitation in nonobstructive HCM is usually mild and occurs in approximately 30% of patients.

Stay updated, free articles. Join our Telegram channel

Jun 12, 2016 | Posted by in CARDIOLOGY | Comments Off on Hypertrophic Cardiomyopathy

Full access? Get Clinical Tree

Get Clinical Tree app for offline access